SXNYCMBZAMIDBO-MUAFOXQISA-N
Compound with spectra: 1 NMR
| SpectraBase Compound ID | FBBnENUCO43 |
|---|---|
| InChI | InChI=1S/C29H48O6Si/c1-9-18(2)28(32)34-25-17-23(35-36(7,8)29(4,5)6)14-20-11-10-19(3)24(27(20)25)13-12-22-15-21(30)16-26(31)33-22/h10-11,14,18-19,21-25,27,30H,9,12-13,15-17H2,1-8H3/t18-,19-,21+,22+,23+,24-,25-,27-/m0/s1 |
| InChIKey | SXNYCMBZAMIDBO-MUAFOXQISA-N |
| Mol Weight | 520.8 g/mol |
| Molecular Formula | C29H48O6Si |
| Exact Mass | 520.322016 g/mol |
| Enantiomer InChIKey | SXNYCMBZAMIDBO-XBUYXJJBSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
ZAKDJVVJTNQRTN-OOQIBZCKSA-N
LYDWUSALVOEBLT-MIRJNQLDSA-N
6'-BETA-HYDROXY-LOVASTATIN
6'-BETA-HYDROXY-SIMVASTATIN
(3'aR,4'aS,8'aS,9'aS)-5'-[(E)-2-[(3'aR,4'aS,8'aS,9'aS)-2',2',5,5-tetramethyl-5'-spiro[1,3-dioxane-2,8'-4,4a,7,8a,9,9a-hexahydro-3aH-naphtho[6,7-d][1,3]dioxole]yl]ethenyl]-2',2',5,5-tetramethylspiro[1,3-dioxane-2,8'-4,4a,7,8a,9,9a-hexahydro-3aH-naphtho[2,3-d][1,3]dioxole]
(4-ALPHA,5-ALPHA,8-BETA,10-ALPHA)-4,10-DIHYDROXY-1,11(13)-GUAIDIEN-12,8-OLIDE
Methyl 7-{1-[(1R,2R,4aR,6R,8S,8aS)-6-[(tert-butydiphenylsilyl)oxy]-8-[(2S)-methyl-1-oxobutyl)oxy]-1,2,4a,5,6,7,8,8a-octahydro-2-methylnaphthalenyl]}-3(R)-[(tert-butyldimethylsilyl)oxy]-5-oxohepten-6-oate
7.beta.-Hydroxy-11.beta.-methyldihydrocostunolide
(2a.alpha.,4a.alpha.,5.beta.,7a.alpha.,7b.alpha.)-2,2a,3,4,4a,5,7a,7b-octahydro-5-methyl-4-oxo-1H-cyclopenta[cd]indene-2,2-di(methoxycarbonyl)
3-O-Acetyl-niveusin C isomer
| Title | Journal or Book | Year |
|---|---|---|
| Complete assignment of 1 H and 13 C NMR data of pravastatin derivatives | Magnetic Resonance in Chemistry | 2008 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.